Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.74 USD | -5.39% | -1.25% | -6.14% |
Financials (USD)
Sales 2024 * | 76.38M | Sales 2025 * | 52.83M | Capitalization | 580M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -141M | EV / Sales 2024 * | 5.48 x |
Net cash position 2024 * | 161M | Net cash position 2025 * | 67.89M | EV / Sales 2025 * | 9.69 x |
P/E ratio 2024 * |
-4.69
x | P/E ratio 2025 * |
-4.44
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.8% |
Latest transcript on Wave Life Sciences Ltd.
1 day | -5.39% | ||
1 week | -1.25% | ||
Current month | -23.18% | ||
1 month | -17.99% | ||
3 months | +7.97% | ||
6 months | -15.51% | ||
Current year | -6.14% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 14-06-30 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 16-11-09 |
Mark Corrigan
BRD | Director/Board Member | 66 | 19-09-03 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 17-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.74 | -5.39% | 397,715 |
24-04-24 | 5.01 | -1.38% | 430,676 |
24-04-23 | 5.08 | +4.96% | 469,439 |
24-04-22 | 4.84 | -0.62% | 492,475 |
24-04-19 | 4.87 | +1.46% | 452,691 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.14% | 580M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.90% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- WVE Stock